Showing results (1011-1020 of 1,489) with videos related to

Sort By:
Pageof 149
Frontiers in Pharmacology|April 10, 2025
<i>Senecio scandens</i> Buch.-Ham. polysaccharides exert anti-atopic dermatitis effects by modulating gut microbiota and the MAPK/NF-κB pathwayZhi-Qin Hu, Shu-Shu Xie, Ming-Yuan Zhou, et al.
Biomolecules|May 4, 2026
Design of TAT-Conjugated Bowman-Birk Trypsin Inhibitor Peptides with Enhanced Antimicrobial and Antiproliferative ActivitiesYing Wang, Yangyang Jiang, Tao Wang, et al.
Pharmaceutics|September 23, 2022
Conjugation of a Cationic Cell-Penetrating Peptide with a Novel Kunitzin-like Trypsin Inhibitor: New Insights for Enhancement of Peptide BioactivitiesJunting Yao, Weining Yin, Yuqing Chen, et al.
Applied Microbiology and Biotechnology|July 31, 2015
Efficient two-step chemo-enzymatic synthesis of all-trans-retinyl palmitate with high substrate concentration and product yieldZhi-Qiang Liu, Ling-Mei Zhou, Peng Liu, et al.
The Review of Scientific Instruments|December 9, 2024
Single cell micro-absorption spectroscopy system with temperature control: System design and spectral analysisYufei Liu, Bo Li, Yue Sun, et al.
The Journal of International Medical Research|August 2, 2021
Systemic lupus erythematosus complicated with reversible posterior encephalopathy syndrome: a case reportDong-Lin Hao, Yan-Li Yang, La-Mei Zhou, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 10, 2022
Emerging nanotherapeutics alleviating rheumatoid arthritis by readjusting the seeds and soilsWenjing Zhang, Yang Chen, Qin Liu, et al.
Chemical Communications (Cambridge, England)|April 3, 2020
Copper-catalyzed tandem cis-carbometallation/cyclization of imine-ynamides with arylboronic acidsHao-Ran Wang, En-He Huang, Chen Luo, et al.
Frontiers in Immunology|September 28, 2020
Immunoregulatory Roles of Extracellular Vesicles and Associated Therapeutic Applications in Lung CancerZhengrong Yin, Jinshuo Fan, Juanjuan Xu, et al.
Annals of Translational Medicine|November 22, 2021
Efficacy and safety of low-dose everolimus combined with endocrine drugs for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancerHui-Qiang Zhang, Jin-Mei Zhou, Shao-Hua Zhang, et al.
Pageof 149